Rivastigmine Tartrate | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Rivastigmine Tartrate
Canada

PharmaCompass Sponsored Ads

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

pharmacompass-2-m-2025-10-20

Rivastigmine Tartrate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

51 API Suppliers, 19 USDMF, 12 CEP/COS, 12 EU WC, 20 KDMF, 5 NDC API, 26 Listed Suppliers, $ API Reference Price

51 API Suppliers
19 USDMF
12 CEP/COS
12 EU WC
20 KDMF
5 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

10 Drugs in Development

10 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

308 FDF Dossiers, 46 FDA Orange Book, 199 Europe, 36 Canada, 14 Australia, 8 South Africa, 5 Listed Dossiers

308 FDF Dossiers
46 FDA Orange Book
199 Europe
36 Canada
14 Australia
8 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 1.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 3MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 4.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE;ORAL - EQ 6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 10 DKSH, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 4 ACG Worldwide, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 BASF, 10 Corel Pharma Chem, 2 DFE Pharma, 1 Finar, 6 Gangwal Chemicals, 4 Ideal Cures, 2 Ingredion Pharma Solutions, 10 Kerry, 1 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 17 Roquette, 8 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Sigachi Industries, 2 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 39 Fillers, Diluents & Binders, 20 Thickeners and Stabilizers, 15 Direct Compression, 15 Controlled & Modified Release, 15 Lubricants & Glidants, 12 Granulation, 10 Film Formers & Plasticizers, 10 Co-Processed Excipients, 9 Empty Capsules, 9 Taste Masking, 8 Disintegrants & Superdisintegrants, 7 Chewable & Orodispersible Aids, 6 Emulsifying Agents, 5 Coloring Agents, 5 Topical, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Rheology Modifiers, 3 Solubilizers, 1 Surfactant & Foaming Agents, 1 Parenteral

44 Coating Systems & Additives
39 Fillers, Diluents & Binders
20 Thickeners and Stabilizers
15 Direct Compression
15 Controlled & Modified Release
15 Lubricants & Glidants
12 Granulation
10 Film Formers & Plasticizers
10 Co-Processed Excipients
9 Empty Capsules
9 Taste Masking
8 Disintegrants & Superdisintegrants
7 Chewable & Orodispersible Aids
6 Emulsifying Agents
5 Coloring Agents
5 Topical
4 Vegetarian Capsules
4 API Stability Enhancers
4 Rheology Modifiers
3 Solubilizers
1 Surfactant & Foaming Agents
1 Parenteral

DIGITAL CONTENT

7 News #PharmaBuzz

7 News #PharmaBuzz

GLOBAL SALES INFORMATION

10 US Medicaid Prescriptions, 12 Regulatory FDF Prices

10 US Medicaid Prescriptions
12 Regulatory FDF Prices

MARKET PLACE

3 APIs

3 APIs

REF. STANDARDS & IMPURITIES

3 EDQM, 2 Others

3 EDQM
2 Others

$ API Ref.Price (USD/KG) : 3,866 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

36 All

01 4APOTEX INC

02 4GENERIC MEDICAL PARTNERS INC

03 8JAMP PHARMA CORPORATION

04 8KNIGHT THERAPEUTICS INC.

05 2MYLAN PHARMACEUTICALS ULC

06 4Pharmascience Inc.

07 6SANDOZ CANADA INCORPORATED

filter Active Ingredients Reset all filters

36 All

01 7RIVASTIGMINE

02 25RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)

03 4Rivastigmine Hydrogen Tartrate

filter Dosage Form Reset all filters

36 All

01 28CAPSULE

02 7PATCH

03 1SOLUTION

filter Brand Name Reset all filters

36 All

01 4APO-RIVASTIGMINE

02 5EXELON

03 1EXELON PATCH 10

04 1EXELON PATCH 15

05 1EXELON PATCH 5

06 4JAMP RIVASTIGMINE

07 4JAMP RIVASTIGMINE CAPSULES

08 4MED-RIVASTIGMINE

09 1MYLAN-RIVASTIGMINE PATCH 10

10 1MYLAN-RIVASTIGMINE PATCH 5

11 4PMS-RIVASTIGMINE

12 4SANDOZ RIVASTIGMINE

13 1SANDOZ RIVASTIGMINE PATCH 10

14 1SANDOZ RIVASTIGMINE PATCH 5

Rivastigmine Tartrate

List of Suppliers

Product Main Page

01

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)

Brand Name : EXELON

Dosage Form : CAPSULE

Dosage Strength : 1.5MG

Packaging : 56/60

Approval Date :

Application Number : 2242115

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)

Brand Name : EXELON

Dosage Form : CAPSULE

Dosage Strength : 3MG

Packaging : 56/60

Approval Date :

Application Number : 2242116

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)

Brand Name : EXELON

Dosage Form : CAPSULE

Dosage Strength : 4.5MG

Packaging : 56/60

Approval Date :

Application Number : 2242117

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)

Brand Name : EXELON

Dosage Form : CAPSULE

Dosage Strength : 6MG

Packaging : 56/60

Approval Date :

Application Number : 2242118

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RIVASTIGMINE (RIVASTIGMINE HYDROGEN TARTRATE)

Brand Name : EXELON

Dosage Form : SOLUTION

Dosage Strength : 2MG/ML

Packaging : 120 ML

Approval Date :

Application Number : 2245240

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

KNIGHT THERAPEUTICS INC.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

RIVASTIGMINE

Brand Name : EXELON PATCH 5

Dosage Form : PATCH

Dosage Strength : 4.6MG/24HOUR

Packaging : 30

Approval Date :

Application Number : 2302845

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Rivastigmine Hydrogen Tartrate

Brand Name : PMS-RIVASTIGMINE

Dosage Form : CAPSULE

Dosage Strength : 1.5MG

Packaging : 60/100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Rivastigmine Hydrogen Tartrate

Brand Name : PMS-RIVASTIGMINE

Dosage Form : CAPSULE

Dosage Strength : 3MG

Packaging : 60/100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Rivastigmine Hydrogen Tartrate

Brand Name : PMS-RIVASTIGMINE

Dosage Form : CAPSULE

Dosage Strength : 4.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Pharmascience Inc.

Indonesia Pharmaceutical Expo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Rivastigmine Hydrogen Tartrate

Brand Name : PMS-RIVASTIGMINE

Dosage Form : CAPSULE

Dosage Strength : 6MG

Packaging : 60/100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!